Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $120,030.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 3,000 shares of the company’s stock in a transaction on Wednesday, March 26th. The stock was sold at an average price of $40.01, for a total transaction of $120,030.00. Following the sale, the chief financial officer now directly owns 18,358 shares of the company’s stock, valued at approximately $734,503.58. This represents a 14.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock opened at $40.15 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The company has a market cap of $114.63 million, a PE ratio of 6.36 and a beta of 0.71. The firm has a fifty day moving average price of $55.79 and a two-hundred day moving average price of $47.44. Kewaunee Scientific Co. has a fifty-two week low of $30.82 and a fifty-two week high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The business had revenue of $67.17 million during the quarter.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

Institutional Trading of Kewaunee Scientific

Hedge funds have recently modified their holdings of the company. Bank of America Corp DE increased its position in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares during the period. IFP Advisors Inc bought a new stake in Kewaunee Scientific in the 4th quarter valued at $36,000. JPMorgan Chase & Co. raised its stake in shares of Kewaunee Scientific by 18,000.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after buying an additional 900 shares in the last quarter. Morgan Dempsey Capital Management LLC bought a new position in shares of Kewaunee Scientific during the 4th quarter worth about $106,000. Finally, Barclays PLC acquired a new stake in shares of Kewaunee Scientific during the 3rd quarter valued at about $121,000. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.